The National Institutes of Health (NIH) is inviting applications for the Diabetes Research Centers (P30 Clinical Trial Optional) grant, aimed at enhancing research efforts in diabetes and related metabolic diseases. This funding opportunity encourages collaboration between basic and clinical investigators by providing shared technical resources and support for pilot studies, with a focus on creating a multidisciplinary research environment. The program requires a minimum of $3 million in peer-reviewed research funding and will provide approximately $7.4 million in total funding, with individual institution budgets capped at $1 million per year, or $1.25 million for significant expansions. Key deadlines include an application open date of May 20, 2024, and a close date of June 18, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.